--- title: COVID-19's Surprising Effect on Cancer description: Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer. canonical: https://time.com/7176558/covid-19-virus-cancer-monocytes/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2024-11-15T17:00:00.000Z article:modified_time: 2026-03-10T23:08:09.130Z article:section: Health og:title: COVID-19's Surprising Effect on Cancer og:description: Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer. og:url: https://time.com/7176558/covid-19-virus-cancer-monocytes/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt2b7cc5f533f01e96/698a9c30db2987ae76272cbe/Bharat-Lab-sample-4.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 2100 og:image:height: 1181 og:image:alt: Bharat Lab og:type: article twitter:card: summary_large_image twitter:title: COVID-19's Surprising Effect on Cancer twitter:description: Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt2b7cc5f533f01e96/698a9c30db2987ae76272cbe/Bharat-Lab-sample-4.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # COVID-19's Surprising Effect on Cancer > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=0b524c2b-4c14-47b9-be63-61628a732557&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=0b524c2b-4c14-47b9-be63-61628a732557&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=0b524c2b-4c14-47b9-be63-61628a732557&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=0b524c2b-4c14-47b9-be63-61628a732557&cr=time-nl-network-2026q3-v1)  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Nov 15, 2024 5:00 PM UTC  In a study investigating how the COVID-19 virus affects cancer, researchers removed cancer-fighting cells from lung tissues of mice for further study. In a study investigating how the COVID-19 virus affects cancer, researchers removed cancer-fighting cells from lung tissues of mice for further study. Northwestern Medicine  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Nov 15, 2024 5:00 PM UTC Viruses don’t often come with silver linings, and infections don’t generally lead to positive health effects. But during the pandemic, some doctors anecdotally began noticing that some people with cancer who got very sick with COVID-19 saw their tumors shrink or grow more slowly. “We didn’t know if it was real, because these patients were so sick,” says Dr. Ankit Bharat, chief of thoracic surgery at Northwestern University. “Was it because the immune system was so triggered by COVID-19 that it also started to kill cancer cells? What was it?” Bharat and his team decided conduct a study to find out if the seeming “benefit” of COVID-19 for these cancer patients could teach them anything about a potential new way to fight cancer—or if it was simply a red herring. They published their findings Nov. 15 in the _Journal of Clinical Investigation_. Using a combination of human cells and animal models, Bharat and his team found that in the presence of SARS-CoV-2, immune cells called monocytes act differently than they normally do. Typically, monocytes, as part of the immune system, cruise the bloodstream and alert other immune cells to the presence of foreign cells or pathogens; some monocytes can attract cancer-killing immune cells to tumors, but others aren't as effective in doing so. That's because in some cases, cancer cells can co-opt monocytes —“like a demon summoning forces,” says Bharat—and form an immune wall protecting the tumor from being discovered and attacked by additional immune defenses. But during a COVID-19 infection, SARS-CoV-2 attaches itself to these monocytes, and by doing so reverts them back to doing their original job: defending the body against cancer. “They look the same, and are still recruited to the tumor sites, but instead of protecting the cancer cells, they start to bring specific natural killer cells—which are the body’s main cells that kill cancer—to these tumor sites,” says Bharat. “So where before the cancer was brainwashing the monocytes into protecting the cancer, the virus now helps them to attack cancer.” **Read More**: [_What It’s Like to Have Long COVID As a Kid_](https://time.com/7160814/long-covid-kid-personal-essay/) It’s a potentially powerful turnabout that—if confirmed by human studies—could represent a new way to control cancer. By analyzing the receptor on the monocytes that the COVID-19 virus attached to, Bharat found a compound that currently isn’t used to treat any disease but is a close mimic of the COVID-19 virus in the way that it binds to the monocyte to induce the cell’s transformation into a cancer-fighting cell. “We can use a drug to cause the same effect that the RNA of the COVID-19 virus was doing,” he says. “By manipulating that pathway through the drug, we might be able to help patients with many different types of cancers, particularly those with stage 4 cancers.” In animal tests, the compound—called muramyl dipeptide (MDP)—reduced tumors by 60% to 70% in mice with human cancers including breast, colon, lung, and melanoma. More studies are needed to confirm whether the cells have the same cancer-fighting effect in people, but there are promising hints. These transformed, cancer-flagging monocytes, called inducible non-classical monocytes, are rare compared to other types of monocytes, but tend to proliferate when inflammation occurs, such as during a COVID-19 infection. Transplant surgeons have previously identified them in people who have had lung and spleen transplants, and Bharat is conducting additional research to understand why the transplant process and COVID-19 infections—both of which activate the immune system—trigger the specific change in the monocytes. Interestingly, the transformation doesn’t occur with all RNA-based viruses; Bharat tested influenza and parainfluenza, which are also RNA viruses, and failed to see the same population of cancer-fighting monocytes emerge. Another intriguing part of the equation, says Bharat, is that this pathway is independent of the T cell immune treatments that are becoming a big part of cancer therapy now, in which doctors boost the population of T cells that can recognize and attack cancer cells. They can be effective, but generally only work for a while, since cancers quickly find ways to circumvent the T cells and become resistant to the therapies. The virus-induced changes in the monocytes, in contrast, aren’t dependent on T cells. Bharat tested the approach in mice genetically bred to lack T cells and still saw a strong effect on tumors in these animals from the monocytes. That means that the monocytes may help shore up the body's response to immunotherapy—and its ability to fight tumors. Much more research is needed before the finding leads to any treatments. But "this approach could potentially be used to promote regression,” he says. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/7176558/covid-19-virus-cancer-monocytes/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/7176558/covid-19-virus-cancer-monocytes/"},"headline":"COVID-19's Surprising Effect on Cancer","datePublished":"2024-11-15T17:00:00.000Z","dateModified":"2026-03-10T23:08:09.130Z","description":"Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer.","url":"https://time.com/7176558/covid-19-virus-cancer-monocytes/","keywords":["COVID-19","healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt2b7cc5f533f01e96/698a9c30db2987ae76272cbe/Bharat-Lab-sample-4.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt2b7cc5f533f01e96/698a9c30db2987ae76272cbe/Bharat-Lab-sample-4.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Bharat Lab","caption":"","creditText":"Northwestern Medicine","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/7176558/covid-19-virus-cancer-monocytes/","name":"COVID-19's Surprising Effect on Cancer"}}]}] ```